Cargando…

Exploiting a chink in the armor: engineering broadly neutralizing monoclonal antibodies for SARS-like viruses

Detalles Bibliográficos
Autores principales:	Cortese, Mirko, Neufeldt, Christopher J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193592/ https://www.ncbi.nlm.nih.gov/pubmed/34117219 http://dx.doi.org/10.1038/s41392-021-00661-w

Ejemplares similares

Looking for Chinks in the Armor of Bacterial Biofilms
por: Monroe, Don
Publicado: (2007)

Finding chinks in the osimertinib resistance armor
por: Leal, Jose Luis, et al.
Publicado: (2020)

Chinks in the Armor? Filaggrin-Depleted Skin Could Increase Environmental Exposures
por: Konkel, Lindsey
Publicado: (2014)

Finding a chink in the armor: Update, limitations, and challenges toward successful antivirals against flaviviruses
por: Komarasamy, Thamil Vaani, et al.
Publicado: (2022)

Recent Advances in Non-Conventional Antimicrobial Approaches for Chronic Wound Biofilms: Have We Found the ‘Chink in the Armor’?
por: Kadam, Snehal, et al.
Publicado: (2019)

B cell engineering in vivo: Accelerating induction of broadly neutralizing antibodies against HIV-1 infection
por: Sun, Caijun, et al.
Publicado: (2023)

Commentary: The time-honored practice of tonometry disinfection – Our ultimate strength or a chink in our anti-glaucoma armor?
por: Ramesh, Prasanna Venkatesh, et al.
Publicado: (2023)

Broad neutralization of SARS-related viruses by human monoclonal antibodies
por: Wec, Anna Z., et al.
Publicado: (2020)

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
por: Rappazzo, C. Garrett, et al.
Publicado: (2021)

A Welcome Chink in Drug Resistance
por: Meadows, Robin
Publicado: (2013)

Broadly neutralizing monoclonal antibodies for HIV prevention
por: Miner, Maurine D., et al.
Publicado: (2021)

An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies
por: Ahmadi, Shirin, et al.
Publicado: (2020)

Human Monoclonal Antibodies Broadly Neutralizing against Influenza B Virus
por: Yasugi, Mayo, et al.
Publicado: (2013)

Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody
por: Li, Fang, et al.
Publicado: (2020)

A broad range of themes in Microbial Biotechnology
por: Daniels, Craig, et al.
Publicado: (2009)

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
por: Rosenberg, Yvonne, et al.
Publicado: (2015)

SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies
por: Yang, Yang, et al.
Publicado: (2021)

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies
por: McCoy, Laura E., et al.
Publicado: (2015)

Characterization of a Broadly Neutralizing Monoclonal Antibody against SARS-CoV-2 Variants
por: Zakir, Tasnim Saifudin, et al.
Publicado: (2022)

Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies
por: Ling, Zhiyang, et al.
Publicado: (2022)

Mechanism of a rabbit monoclonal antibody broadly neutralizing SARS-CoV-2 variants
por: Guo, Hangtian, et al.
Publicado: (2023)

A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III
por: Hu, Dan, et al.
Publicado: (2019)

SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines
por: Li, Maochen, et al.
Publicado: (2022)

Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants
por: Ko, Hae Li, et al.
Publicado: (2023)

Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody
por: Tortorici, M. Alejandra, et al.
Publicado: (2021)

Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein
por: Owsianka, Ania M., et al.
Publicado: (2008)

Neutralization of Japanese Encephalitis Virus by heme-induced broadly reactive human monoclonal antibody
por: Gupta, Nimesh, et al.
Publicado: (2015)

Development and characterization of novel chimeric monoclonal antibodies for broad spectrum neutralization of rabies virus
por: Kim, Pan Kyeom, et al.
Publicado: (2017)

Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513
por: Wong, Yee Hwa, et al.
Publicado: (2018)

Armored Geomembrane Cover Engineering
por: Foye, Kevin
Publicado: (2011)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

Broad dengue neutralization in mosquitoes expressing an engineered antibody
por: Buchman, Anna, et al.
Publicado: (2020)

SARS-CoV-2 monoclonal antibodies with therapeutic potential: Broad neutralizing activity and No evidence of antibody-dependent enhancement
por: Wang, Ying-Ting, et al.
Publicado: (2021)

A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets
por: Zhang, Zhigang, et al.
Publicado: (2021)

Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses
por: VanBlargan, Laura A., et al.
Publicado: (2021)

Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors
por: Kubota-Koketsu, Ritsuko, et al.
Publicado: (2009)

Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
por: Mahomed, Sharana, et al.
Publicado: (2020)

Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
por: Ma, Hang, et al.
Publicado: (2022)

Modeling Neutralization Kinetics of HIV by Broadly Neutralizing Monoclonal Antibodies in Genital Secretions Coating the Cervicovaginal Mucosa
por: McKinley, Scott A., et al.
Publicado: (2014)

Delivering therapeutic proteins in vivo by engineered DNA-free virus-like particles
por: Lim, Theam Soon
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ka8ckb48ksdo23r7qmn0gcut2l